Lantheus to Present at the Jefferies London Healthcare Conference

LNTH 11.13.2024

SERA-AI Powered Highlights
Date of Upcoming Event:2024-11-20
Name of Upcoming Event:Jefferies London Healthcare Conference
Full Press ReleaseSEC FilingsOur LNTH Tweets

About Gravity Analytica

Recent News

  • 01.13.2025 - Lantheus' Acquisition of Life Molecular Imaging Conference Call
  • 01.13.2025 - Lantheus to Acquire Life Molecular Imaging for an Upfront Payment of $350 Million to Accelerate Innovation for Patients in the Growing Alzheimer’s Disease Radiodiagnostic Market
  • 12.18.2024 - Paul K. Choi

Recent Filings

  • 01.17.2025 - 4 Statement of changes in beneficial ownership of securities
  • 01.15.2025 - 144 Report of proposed sale of securities
  • 01.13.2025 - 8-K Current report
PDF Version

BEDFORD, Mass.,Nov. 13, 2024(GLOBE NEWSWIRE) --Lantheus Holdings, Inc.(“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, today announcedBob Marshall, Chief Financial Officer and Treasurer, will present at theJefferies London Healthcare Conferenceat1:00 p.m. GMT(8 a.m. EST) onWednesday, November 20.

To access a live webcast of the presentation, please visit the Investors section of the Company’s website atwww.lantheus.com. A replay of the webcast will be available on the Company’s website for at least 30 days following the live presentation.

AboutLantheusLantheusis the leading radiopharmaceutical-focused company, delivering life-changing science to enable clinicians to Find, Fight and Follow disease to deliver better patient outcomes. Headquartered inMassachusettswith offices inCanadaandSweden,Lantheushas been providing radiopharmaceutical solutions for more than 65 years. For more information, visitwww.lantheus.com.

Contacts:Mark KinarneyVice President, Investor Relations978-671-8842ir@lantheus.com

Melissa DownsSenior Director,External Communications646-975-2533media@lantheus.com

Primary Logo

Source: Lantheus Holdings, Inc.

Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com